Exor N.V. (LON:0RKY)
80.95
-2.25 (-2.70%)
At close: Apr 3, 2025
Exor N.V. Revenue
In the year 2024, Exor N.V. had annual revenue of 15.40B EUR, down -66.09%. Exor N.V. had revenue of 255.00M in the half year ending December 31, 2024, a decrease of -98.90%.
Revenue
15.40B EUR
Revenue Growth
-66.09%
P/S Ratio
n/a
Revenue / Employee
669.35M EUR
Employees
23
Market Cap
14.64B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15.40B | -30.01B | -66.09% |
Dec 31, 2023 | 45.41B | 3.56B | 8.51% |
Dec 31, 2022 | 41.84B | 8.23B | 24.47% |
Dec 31, 2021 | 33.62B | 6.83B | 25.47% |
Dec 31, 2020 | 26.79B | -116.96B | -81.36% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
BP p.l.c. | 149.68B |
British American Tobacco p.l.c. | 25.87B |